Abstract
Cancer does not treat all its victims equally. Some progress rapidly from diagnosis to death; in others the disease advances almost imperceptibly. This variation in malignant expression is certainly apparent from one type of cancer to another. In the case of melanoma and basal cell carcinomas of the skin, for example, even the same tumor type may act differently in two patients. As a model of heterogeneity, prostate cancer is of particular importance because of its variable behavior in patients belonging to various minorities (Young et al. 1984).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brawn PN, Ayala AG, von Eschenbach AC, et al: Histologic grading study of prostate adenocarcinoma. Cancer 1982; 49:525–532.
Dayal HH, Chiu C: Factors associated with racial differences in survival for prostatic carcinoma. J Clin Res 1982; 35:553–560.
Gleason DF, Mellinger GT, and The Veterans Administration Cooperative Urological Research Group: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 3:58–64.
Grayhack JT, Keeler TC, Kozlowski JM: Carcinoma of the prostate: Hormonal therapy. Cancer 1987; 60:589–601.
Haenszel W, Kurihara M: Studies of Japanese migrants I. Mortality from cancer and other diseases among Japanese in the United States. JNCI 1960; 40:43–68.
Johnson DE, Swanson DA, von Eschenbach AC. Tumors of the genitourinary tract. In Tanagho EA, McAninch JW, eds, General Urology, 12th Ed. Norwalk: Appleton & Lange, 1988.
Logothetis CJ, Samuels ML, von Eschenbach AC, et al: Doxorubicin, mitomycin-C and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate with a note on the staging metastatic prostate cancer. J Clin Onocol 1983; 1:368–379.
Mettlin C, Natarajan N: Epidemiologic observation from the American College of Surgeons survey on prostate cancer. Prostate 1983; 4:323–331.
Rose DP: The biochemical epidemiology of prostatic carcinoma. In: Dietary Fat and Cancer, New York: Alan R Liss, 1986, pp 43–68.
Thind, IS, Najem R, Paradise J, et al: Cancer among blacks in Newark, New Jersey 1970–1976. Cancer 1982; 50:180–186.
Young JL Jr, Ries GL, Pollack ES: Cancer patient survival among ethnic groups in the United States. JNCI 1984; 73:341–352.
Whitmore WF Jr: The natural history of prostate cancer. Cancer 1973; 31:1104–1112.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
von Eschenbach, A.C. (1989). The Heterogeneity of Prostate Cancer: Implications for Research. In: Jones, L.A. (eds) Minorities and Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3630-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3630-6_17
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8185-6
Online ISBN: 978-1-4612-3630-6
eBook Packages: Springer Book Archive